To post, or not to post, that is the question

Hamlet would probably advise that MDs chill out on the whole posting thing. According to a new study led by Dr. Kevin Koo of Dartmouth-Hitchcock Medical Center, young doctors are having an issue with hitting “Post” well beyond the lines of professionalism and ethics. The study, which focused on urologist new grads, found that 40% of those with publicly identifiable Facebook profiles contained iffy content. And by iffy we mean those “What happened last night?” pictures all the way to divulging patient information. Great. Apparently, millennials grow up to be doctors, too. Remember, when in doubt, hit delete. Here are the AMA’s guidelines for social media use for all you docs who skipped ethics class. What do you think? See this week’s FastPoll™ question below.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

5. Kard-#ad-shians

Social media is the wild west of the marketing world. Very little law/regulation and swift punishment for doing something wrong – i.e. Duchesnay and the social media queen, Kim Kardashian, whose Diclegis debacle intimidated the entire pharma industry from venturing into this space. Sure the FDA has set guidelines, but they make as much sense as why the Kardashians are famous to begin with. Pharma can’t ignore social media forever, though, and thanks to TruthInAdvertising.org, a door may have just been opened. Because of them, the whole Kardashian clan is now using “#ad” in all of their endorsements – adding more transparency to advertisements, which is what the FDA is really looking for. Still, good luck fitting all the benefits and risks of your product into 140 charact…

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

1. Twitter to the rescue?

UnitedHealthcare has announced that Medtronic will soon become the sole in-network insulin pump manufacturer for UHC’s commercial and Medicaid plan members. Though patients are permitted to continue using their existing pump until it is out of warranty and needs to be replaced, patients are not exactly jazzed about this new lack of options.  Patients, advocacy groups, and not surprisingly, Medtronic’s competitor Tandem Diabetes Care, are pushing back publically. Patients and advocacy groups are using Twitter hashtags #DiabetesAccessMatters and #MyPumpMyChoice to voice their displeasure.  One tweet reads, “If you can’t decide what to have for lunch just ask @MDT_Diabetes & @myUHC they know everything #MypumpMyChoice.” Whether sarcasm and tweets will be enough to change UHC’s policy remains to be seen.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn